{"PubmedArticle": [{"MedlineCitation": {"KeywordList": [["SARS-CoV-2coronavirus", "combination treatment", "microorganisms", "pandemic", "target"]], "GeneralNote": [], "OtherAbstract": [], "CitationSubset": ["IM"], "SpaceFlightMission": [], "OtherID": [], "InvestigatorList": [], "PMID": "35234563", "DateCompleted": {"Year": "2022", "Month": "03", "Day": "14"}, "DateRevised": {"Year": "2022", "Month": "12", "Day": "07"}, "Article": {"ArticleDate": [], "Language": ["eng"], "ELocationID": ["10.1080/13880209.2022.2039215"], "Journal": {"ISSN": "1744-5116", "JournalIssue": {"Volume": "60", "Issue": "1", "PubDate": {"Year": "2022", "Month": "Dec"}}, "Title": "Pharmaceutical biology", "ISOAbbreviation": "Pharm Biol"}, "ArticleTitle": "The vital role of animal, marine, and microbial natural products against COVID-19.", "Pagination": {"StartPage": "509", "EndPage": "524", "MedlinePgn": "509-524"}, "Abstract": {"AbstractText": ["Since the outbreak of SARS-CoV-2, researchers have been working on finding ways to prevent viral entry and pathogenesis. Drug development from naturally-sourced pharmacological constituents may be a fruitful approach to COVID-19 therapy.", "Most of the published literature has focussed on medicinal plants, while less attention has been given to biodiverse sources such as animal, marine, and microbial products. This review focuses on highlighting natural products and their derivatives that have been evaluated for antiviral, anti-inflammatory, and immunomodulatory properties.", "We searched electronic databases such as PubMed, Scopus, Science Direct and Springer Link to gather raw data from publications up to March 2021, using terms such as 'natural products', marine, micro-organism, and animal, COVID-19. We extracted a number of documented clinical trials of products that were tested <i>in silico, in\u00a0vitro</i>, and <i>in\u00a0vivo</i> which paid specific attention to chemical profiles and mechanisms of action.", "Various classes of flavonoids, 2 polyphenols, peptides and tannins were found, which exhibit inhibitory properties against viral and host proteins, including 3CLpro, PLpro, S, hACE2, and NF-\u03baB, many of which are in different phases of clinical trials.", "The synergistic effects of logical combinations with different mechanisms of action emphasizes their value in COVID19 management, such as iota carrageenan nasal spray, ermectin oral drops, omega-3 supplementation, and a quadruple treatment of zinc, quercetin, bromelain, and vitamin C. Though <i>in\u00a0vivo</i> efficacy of these compounds has yet to be established, these bioproducts are potentially useful in counteracting the effects of SARS-CoV-2."]}, "AuthorList": [{"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Alqathama", "ForeName": "Aljawharah A", "Initials": "AA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Natural Products and Alternative Medicines, College of Clinical Pharmacy, Imam Abdulrahman Bin Faisal University, Dammam, Saudi Arabia."}], "LastName": "Ahmad", "ForeName": "Rizwan", "Initials": "R"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Alsaedi", "ForeName": "Ruba B", "Initials": "RB"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Alghamdi", "ForeName": "Raghad A", "Initials": "RA"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Abkar", "ForeName": "Ekram H", "Initials": "EH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacognosy, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Alrehaly", "ForeName": "Rola H", "Initials": "RH"}, {"Identifier": [], "AffiliationInfo": [{"Identifier": [], "Affiliation": "Department of Pharmacology and Toxicology, Faculty of Pharmacy, Umm Al-Qura University, Makkah, Saudi Arabia."}], "LastName": "Abdalla", "ForeName": "Ashraf N", "Initials": "AN"}], "PublicationTypeList": ["Journal Article", "Review"]}, "MedlineJournalInfo": {"Country": "England", "MedlineTA": "Pharm Biol", "NlmUniqueID": "9812552", "ISSNLinking": "1388-0209"}, "ChemicalList": [{"RegistryNumber": "0", "NameOfSubstance": "Anti-Inflammatory Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Antiviral Agents"}, {"RegistryNumber": "0", "NameOfSubstance": "Biological Products"}, {"RegistryNumber": "0", "NameOfSubstance": "Immunomodulating Agents"}], "MeshHeadingList": [{"QualifierName": [], "DescriptorName": "Animals"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacology"], "DescriptorName": "Anti-Inflammatory Agents"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacology"], "DescriptorName": "Antiviral Agents"}, {"QualifierName": ["isolation & purification", "pharmacology"], "DescriptorName": "Biological Products"}, {"QualifierName": ["virology"], "DescriptorName": "COVID-19"}, {"QualifierName": ["methods"], "DescriptorName": "Drug Development"}, {"QualifierName": [], "DescriptorName": "Drug Synergism"}, {"QualifierName": [], "DescriptorName": "Humans"}, {"QualifierName": ["administration & dosage", "isolation & purification", "pharmacology"], "DescriptorName": "Immunomodulating Agents"}, {"QualifierName": [], "DescriptorName": "COVID-19 Drug Treatment"}], "CoiStatement": "The authors declare no conflict of interest in the present article."}, "PubmedData": {"ReferenceList": [{"Reference": [{"Citation": "Aatif M, Muteeb G, Alsultan A, Alshoaibi A, Khelif BY.. 2021. Dieckol and its derivatives as potential inhibitors of SARS-CoV-2 spike protein (UK strain: VUI 202012/01): a computational study. Mar Drugs. 19(5):1\u201317.", "ArticleIdList": ["PMC8145291", "33922914"]}, {"Citation": "Abdo N, Moheyeldin O, Shehata MG, El Sohaimy S.. 2021. Inhibition of COVID-19 RNA-dependent RNA polymerase by natural bioactive compounds: molecular docking analysis. Egypt J Chem. 64:1989\u20132001."}, {"Citation": "Abedi F, Ghasemi S, Farkhondeh T, Azimi-Nezhad M, Shakibaei M, Samarghandian S.. 2021. Possible potential effects of honey and its main components against Covid-19 infection. Dose Response. 19(1):1559325820982423\u20131559325820982423.", "ArticleIdList": ["PMC8020257", "33867892"]}, {"Citation": "Agrawal PK, Agrawal C, Blunden G.. 2020. Quercetin: antiviral significance and possible COVID-19 integrative considerations. Nat Prod Commun. 15(12):1934578X2097629\u20131934578X20976293."}, {"Citation": "Agrawal PK, Agrawal C, Blunden G.. 2021. Rutin: a potential antiviral for repurposing as a SARS-CoV-2 main protease (Mpro) inhibitor. Nat Prod Commun. 16(4):19."}, {"Citation": "Alamri MA, Altharawi A, Alabbas AB, Alossaimi MA, Alqahtani SM.. 2020. Structure-based virtual screening and molecular dynamics of phytochemicals derived from Saudi medicinal plants to identify potential COVID-19 therapeutics. Arab J Chem. 13(9):7224\u20137234.", "ArticleIdList": ["PMC7415226", "34909058"]}, {"Citation": "Al-Horani RA, Kar S, Aliter KF.. 2020. Potential anti-COVID-19 therapeutics that block the early stage of the viral life cycle: structures, mechanisms, and clinical trials. Int J Mol Sci. 21(15):1\u201341.", "ArticleIdList": ["PMC7432953", "32718020"]}, {"Citation": "Al-Rabia M, Alhakamy N, Ahmed O, Eljaaly K, Alaofi A, Mostafa A, Asfour H, Aldarmahi A, Darwish K, Ibrahim T, et al. . 2021. Repurposing of sitagliptin- melittin optimized nanoformula against SARS-CoV-2: antiviral screening and molecular docking studies. Pharmaceutics. 13(3):307\u2013319.", "ArticleIdList": ["PMC8025909", "33652894"]}, {"Citation": "Alsobaie S. 2021. Understanding the molecular biology of SARS-CoV-2 and the COVID-19 pandemic: a review. Infect Drug Resist. 14:2259\u20132268.", "ArticleIdList": ["PMC8215902", "34163190"]}, {"Citation": "Arnardottir H, Pawelzik SC, \u00d6hlund Wistbacka U, Artiach G, Hofmann R, Reinholdsson I, Braunschweig F, Tornvall P, Religa D, B\u00e4ck M.. 2020. Stimulating the resolution of inflammation through Omega-3 polyunsaturated fatty acids in COVID-19: rationale for the COVID-Omega-F trial. Front Physiol. 11(624657):624657.", "ArticleIdList": ["PMC7830247", "33505321"]}, {"Citation": "Arunkumar M, Gunaseelan S, Kubendran Aravind M, Mohankumar V, Anupam P, Harikrishnan M, Siva A, Ashokkumar B, Varalakshmi P.. 2021. Marine algal antagonists targeting 3CL protease and spike glycoprotein of SARS-CoV-2: a computational approach for anti-COVID-19 drug discovery. J Biomol Struct Dyn. 39(3):1\u201328.", "ArticleIdList": ["PMC8146311", "34014150"]}, {"Citation": "Ashhurst AS, Tang AH, Fajtov\u00e1 P, Yoon M, Aggarwal A, Stoye A, Larance M, Beretta L, Drelich A, Skinner D, et al. . 2020. Potent in\u00a0vitro anti-SARS-CoV-2 activity by gallinamide A and analogues via inhibition of cathepsin. L. bioRxiv. 1(24):1\u201326.", "ArticleIdList": ["PMC8577376", "34730959"]}, {"Citation": "Berretta AA, Silveira MAD, C\u00f3ndor Capcha JM, De Jong D.. 2020. Propolis and its potential against SARS-CoV-2 infection mechanisms and COVID-19 disease: running title: propolis against SARS-CoV-2 infection and COVID-19. Biomed Pharmacother. 131:110622\u2013110616.", "ArticleIdList": ["PMC7430291", "32890967"]}, {"Citation": "Buszko M, Nita-Lazar A, Park J-H, Schwartzberg PL, Verthelyi D, Young HA, Rosenberg AS.. 2021. Lessons learned: new insights on the role of cytokines in COVID-19. Nat Immunol. 22(4):404\u2013411.", "ArticleIdList": ["PMC9317654", "33723418"]}, {"Citation": "Cai Y, Xu W, Gu C, Cai X, Qu D, Lu L, Xie Y, Jiang S.. 2020. Griffithsin with a broad-spectrum antiviral activity by binding glycans in viral glycoprotein exhibits strong synergistic effect in combination with a pan-coronavirus fusion inhibitor targeting SARS-CoV-2 spike S2 subunit. Virol Sin. 35(6):857\u2013860.", "ArticleIdList": ["PMC7554295", "33052520"]}, {"Citation": "Caprazli T, Keke\u00e7o\u011flu M.. 2021. Bal Arisi Zehr\u0130n\u0130n Kompoz\u0130syonunu Ve \u00dcret\u0130m M\u0130ktarini Etk\u0130leyen Fakt\u00f6rler. Uludag Aricilik Derg. 21(1):132\u2013145."}, {"Citation": "Chakravarti R, Singh R, Ghosh A, Dey D, Sharma P, Velayutham R, Roy S, Ghosh D.. 2021. A review on potential of natural products in the management of COVID-19. RSC Adv. 11(27):16711\u201316735."}, {"Citation": "Chourasia M, Koppula PR, Battu A, Ouseph MM, Singh AK.. 2021. EGCG, a green tea catechin, as a potential therapeutic agent for symptomatic and asymptomatic SARS-CoV-2 infection. Molecules. 26(5):1200.", "ArticleIdList": ["PMC7956763", "33668085"]}, {"Citation": "ClinicalTrials. 2021. Effect of quercetin on prophylaxis and treatment of COVID-19. 2020. Bethesda (MD): ClinicalTrials. Gov; [accessed 2021 May 10]. https://clinicaltrials.gov/."}, {"Citation": "Coelho C, Gallo G, Campos CB, Hardy L, W\u00fcrtele M.. 2020. Biochemical screening for SARS-CoV-2 main protease inhibitors. PloS One. 15(10):e0240079.", "ArticleIdList": ["PMC7537881", "33022015"]}, {"Citation": "Di Pierro F, Derosa G, Maffioli P, Bertuccioli A, Togni S, Riva A, Allegrini P, Khan A, Khan S, Khan BA, et al. . 2021. Possible therapeutic effects of adjuvant quercetin supplementation against early-stage COVID-19 infection: a prospective, randomized, controlled, and open-label study. Int J Gen Med. 14:2359\u20132366.", "ArticleIdList": ["PMC8197660", "34135619"]}, {"Citation": "Ding Y, Zhu X, Hao L, Zhao M, Hua Q, An F.. 2020. Bioactive indolyl diketopiperazines from the marine derived endophytic Aspergillus versicolor DY180635. Mar Drugs. 18(7):338.", "ArticleIdList": ["PMC7401283", "32605149"]}, {"Citation": "Duan L, Zheng Q, Zhang H, Niu Y, Lou Y, Wang H.. 2020. The SARS-CoV-2 spike glycoprotein biosynthesis, structure, function, and antigenicity: implications for the design of spike-based vaccine immunogens. Front Immunol. 11(2593):1\u201312.", "ArticleIdList": ["PMC7575906", "33117378"]}, {"Citation": "El-Demerdash A, Metwaly AM, Hassan A, Abd El-Aziz TM, Elkaeed EB, Eissa IH, Arafa RK, Stockand JD.. 2021. Comprehensive virtual screening of the antiviral potentialities of marine polycyclic guanidine alkaloids against SARS-CoV-2 (COVID-19). Biomolecules. 11(3):460.", "ArticleIdList": ["PMC8003478", "33808721"]}, {"Citation": "Elfiky AA. 2021. Natural products may interfere with SARS-CoV-2 attachment to the host cell. J Biomol Struct Dyn. 39:3194\u20133203.", "ArticleIdList": ["PMC7212544", "32340551"]}, {"Citation": "Fitton JH, Park AY, Karpiniec SS, Stringer DN.. 2020. Fucoidan and lung function: value in viral infection. Mar Drugs. 19(1):4.", "ArticleIdList": ["PMC7824479", "33374149"]}, {"Citation": "Gao T, Gao Y, Liu X, Nie Z, Sun H, Lin K, Peng H, Wang S.. 2021. Identification and functional analysis of the SARS-COV-2 nucleocapsid protein. BMC Microbiol. 21(1):58.", "ArticleIdList": ["PMC7898026", "33618668"]}, {"Citation": "Geahchan S, Ehrlich H, Rahman MA.. 2021. The anti-viral applications of marine resources for COVID-19 treatment: an overview. Mar Drugs. 19(8):409.", "ArticleIdList": ["PMC8402008", "34436248"]}, {"Citation": "Gentile D, Patamia V, Scala A, Sciortino MT, Piperno A, Rescifina A.. 2020. Putative inhibitors of SARS-CoV-2 main protease from a library of marine natural products: a virtual screening and molecular modeling study. Mar Drugs. 18(4):225.", "ArticleIdList": ["PMC7231030", "32340389"]}, {"Citation": "Glinsky GV. 2020. Tripartite combination of candidate pandemic mitigation agents: Vitamin D, quercetin, and estradiol manifest properties of medicinal agents for targeted mitigation of the COVID-19 pandemic defined by genomics-guided tracing of SARS-CoV-2 targets in human cells. Biomedicines. 8(5):129\u2013126.", "ArticleIdList": ["PMC7277789", "32455629"]}, {"Citation": "Gouda AS, M\u00e9garbane B.. 2021. Snake venom-derived bradykinin-potentiating peptides: a promising therapy for COVID-19? Drug Dev Res. 82(1):38\u201348.", "ArticleIdList": ["PMC7436322", "32761647"]}, {"Citation": "Gu H, Han SM, Park K-K.. 2020. Therapeutic effects of apamin as a bee venom component for non-neoplastic disease. Toxins. 12(3):195\u2013117.", "ArticleIdList": ["PMC7150898", "32204567"]}, {"Citation": "Guler HI, Tatar G, Yildiz O, Belduz AO, Kolayli S.. 2021. Investigation of potential inhibitor properties of ethanolic propolis extracts against ACE-II receptors for COVID-19 treatment by molecular docking study. Arch Microbiol. 203:3557\u20133564.", "ArticleIdList": ["PMC8098016", "33950349"]}, {"Citation": "Haggag YA, El-Ashmawy NE, Okasha KM.. 2020. Is hesperidin essential for prophylaxis and treatment of COVID-19 Infection? Med Hypotheses. 144:109957.", "ArticleIdList": ["PMC7274964", "32531538"]}, {"Citation": "Hamoda AM, Fayed B, Ashmawy NS, El-Shorbagi A-NA, Hamdy R, Soliman SSM.. 2021. Marine sponge is a promising natural source of anti-SARS-CoV-2 scaffold. Front Pharmacol. 12(1161):1\u20139.", "ArticleIdList": ["PMC8165660", "34079462"]}, {"Citation": "Haque SM, Ashwaq O, Sarief A, Mohamed AKAJ.. 2020. A comprehensive review about SARS-CoV-2. Future Virol. 15(9):625\u2013648.", "ArticleIdList": ["PMC7664148", "33224265"]}, {"Citation": "Hariharan A, Hakeem AR, Radhakrishnan S, Reddy MS, Rela M.. 2021. The role and therapeutic potential of NF-kappa-B pathway in severe COVID-19 patients. Inflammopharmacology. 29(1):91\u2013100.", "ArticleIdList": ["PMC7648206", "33159646"]}, {"Citation": "Hashem H. 2020. In silico approach of some selected honey constituents as SARS-CoV-2 main protease (COVID-19) inhibitors. Eurasian J Med Oncol. 4(3): 196\u2013200."}, {"Citation": "Hassan SA, Sheikh FN, Jamal S, Ezeh JK, Akhtar A.. 2020. Coronavirus (COVID-19): a review of clinical features, diagnosis, and treatment. Cureus. 12(3):e7355.", "ArticleIdList": ["PMC7170025", "32328367"]}, {"Citation": "Hathaway D, Pandav K, Patel M, Riva-Moscoso A, Singh BM, Patel A, Min ZC, Singh-Makkar S, Sana MK, Sanchez-Dopazo R, et al. . 2020. Omega 3 fatty acids and COVID-19: a comprehensive review. Infect Chemother. 52(4):478\u2013495.", "ArticleIdList": ["PMC7779984", "33377319"]}, {"Citation": "Hu X, Cai X, Song X, Li C, Zhao J, Luo W, Zhang Q, Ekumi IO, He Z.. 2020. Possible SARS-coronavirus 2 inhibitor revealed by simulated molecular docking to viral main protease and host toll-like receptor. Future Virol. 16(6):1\u201310."}, {"Citation": "Jain AS, Sushma P, Dharmashekar C, Beelagi MS, Prasad SK, Shivamallu C, Prasad A, Syed A, Marraiki N, Prasad KS.. 2021. In silico evaluation of flavonoids as effective antiviral agents on the spike glycoprotein of SARS-CoV-2. Saudi J Biol Sci. 28(1):1040\u20131051.", "ArticleIdList": ["PMC7783825", "33424398"]}, {"Citation": "Jakubczyk D, Dussart F.. 2020. Selected fungal natural products with antimicrobial properties. Molecules. 25(4):911.", "ArticleIdList": ["PMC7070998", "32085562"]}, {"Citation": "Kandeel M, Abdelrahman AHM, Oh-Hashi K, Ibrahim A, Venugopala KN, Morsy MA, Ibrahim MAA.. 2020. Repurposing of FDA-approved antivirals, antibiotics, anthelmintics, antioxidants, and cell protectives against SARS-CoV-2 papain-like protease. J Biomol Struct Dyn. 39(14):1\u20138.", "ArticleIdList": ["PMC7332862", "32597315"]}, {"Citation": "Khalil A, Tazeddinova D.. 2020. The upshot of polyphenolic compounds on immunity amid COVID-19 pandemic and other emerging communicable diseases: an appraisal. Nat Prod Bioprospect. 10(6):411\u2013429.", "ArticleIdList": ["PMC7558243", "33057955"]}, {"Citation": "Khan SL, Siddiqui FA.. 2020. Beta-Sitosterol: as immunostimulant, antioxidant and inhibitor of SARS-CoV-2 spike glycoprotein. Arch Pharmacol Thera. 2(1):1\u20135."}, {"Citation": "Kumar V, Dhanjal JK, Kaul SC, Wadhwa R, Sundar D.. 2021. Withanone and caffeic acid phenethyl ester are predicted to interact with main protease (Mpro) of SARS-CoV-2 and inhibit its activity. J Biomol Struct Dyn. 39(11):3842\u20133854.", "ArticleIdList": ["PMC7284143", "32431217"]}, {"Citation": "Li Y, Zhang L, Wang X, Wu W, Qin R.. 2019. Effect of syringic acid on antioxidant biomarkers and associated inflammatory markers in mice model of asthma. Drug Dev Res. 80(2):253\u2013261.", "ArticleIdList": ["30474283"]}, {"Citation": "Ligon BL. 2004. Penicillin: its discovery and early development. Semin Pediatr Infect Dis. 15(1):52\u201357.", "ArticleIdList": ["15175995"]}, {"Citation": "Lima WG, Brito JCM, da Cruz Nizer WS.. 2021. Bee products as a source of promising therapeutic and chemoprophylaxis strategies against COVID-19 (SARS-CoV-2). Phytother Res. 35(2):743\u2013750.", "ArticleIdList": ["PMC7536959", "32945590"]}, {"Citation": "Lin T-Y, Hsieh C-L.. 2020. Clinical applications of bee venom acupoint injection. Toxins. 12(10):618\u2013625.", "ArticleIdList": ["PMC7601520", "32992601"]}, {"Citation": "Malve H. 2016. Exploring the ocean for new drug developments: marine pharmacology. J Pharm Bioallied Sci. 8(2):83\u201391.", "ArticleIdList": ["PMC4832911", "27134458"]}, {"Citation": "Mandal MD, Mandal S.. 2011. Honey: its medicinal property and antibacterial activity. Asian Pac J Trop Biomed. 1(2):154\u2013160.", "ArticleIdList": ["PMC3609166", "23569748"]}, {"Citation": "Mhatre S, Srivastava T, Naik S, Patravale V.. 2021. Antiviral activity of green tea and black tea polyphenols in prophylaxis and treatment of COVID-19: a review. Phytomedicine. 85:153286\u2013153288.", "ArticleIdList": ["PMC7367004", "32741697"]}, {"Citation": "Michel CJ, Mayer C, Poch O, Thompson JD.. 2020. Characterization of accessory genes in coronavirus genomes. Virol J. 17(1):131\u2013113.", "ArticleIdList": ["PMC7450977", "32854725"]}, {"Citation": "Mishra CB, Pandey P, Sharma RD, Malik MZ, Mongre RK, Lynn AM, Prasad R, Jeon R, Prakash A.. 2021. Identifying the natural polyphenol catechin as a multi-targeted agent against SARS-CoV-2 for the plausible therapy of COVID-19: an integrated computational approach. Brief Bioinform. 22(2):1346\u20131360.", "ArticleIdList": ["PMC7799228", "33386025"]}, {"Citation": "Morokutti-Kurz M, Fr\u00f6ba M, Graf P, Gro\u00dfe M, Grassauer A, Auth J, Schubert U, Prieschl-Grassauer E.. 2021. Iota-carrageenan neutralizes SARS-CoV-2 and inhibits viral replication in\u00a0vitro. PLoS One. 16(2):e0237480.", "ArticleIdList": ["PMC7888609", "33596218"]}, {"Citation": "Mouffouk C, Mouffouk S, Mouffouk S, Hambaba L, Haba H.. 2021. Flavonols as potential antiviral drugs targeting SARS-CoV-2 proteases (3CLpro and PLpro), spike protein, RNA-dependent RNA polymerase (RdRp) and angiotensin-converting enzyme II receptor (ACE2)). Eur J Pharmacol. 891:173759\u2013173711.", "ArticleIdList": ["PMC7691142", "33249077"]}, {"Citation": "Neufurth M, Wang X, Tolba E, Lieberwirth I, Wang S, Schr\u00f6der HC, M\u00fcller WEG.. 2020. The inorganic polymer, polyphosphate, blocks binding of SARS-CoV-2 spike protein to ACE2 receptor at physiological concentrations. Biochem Pharmacol. 182:114215.", "ArticleIdList": ["PMC7474874", "32905794"]}, {"Citation": "Nguyen TTH, Jung J-H, Kim M-K, Lim S, Choi J-M, Chung B, Kim D-W, Kim D.. 2021. The inhibitory effects of plant derivate polyphenols on the main protease of SARS coronavirus 2 and their structure\u2013activity relationship. Molecules. 26(7):1924\u20131915.", "ArticleIdList": ["PMC8036510", "33808054"]}, {"Citation": "Ou X, Liu Y, Lei X, Li P, Mi D, Ren L, Guo L, Guo R, Chen T, Hu J, et al. . 2020. Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoV. Nat Commun. 11(1):1620.", "ArticleIdList": ["PMC7100515", "32221306"]}, {"Citation": "Pal A, Squitti R, Picozza M, Pawar A, Rongioletti M, Dutta AK, Sahoo S, Goswami K, Sharma P, Prasad R.. 2021. Zinc and COVID-19: basis of current clinical trials. Biol Trace Elem Res. 199(8):2882\u20132892.", "ArticleIdList": ["PMC7580816", "33094446"]}, {"Citation": "Pal M, Berhanu G, Desalegn C, Kandi V.. 2020. Severe acute respiratory syndrome Coronavirus-2 (SARS-CoV-2): an update. Cureus. 12(3):1\u201313.", "ArticleIdList": ["PMC7182166", "32337143"]}, {"Citation": "Park J-Y, Kim JH, Kwon JM, Kwon H-J, Jeong HJ, Kim YM, Kim D, Lee WS, Ryu YB.. 2013. Dieckol, a SARS-CoV 3CL(pro) inhibitor, isolated from the edible brown algae Ecklonia cava. Bioorg Med Chem. 21(13):3730\u20133737.", "ArticleIdList": ["PMC7126891", "23647823"]}, {"Citation": "Pascarella G, Strumia A, Piliego C, Bruno F, Del Buono R, Costa F, Scarlata S, Agr\u00f2 FE.. 2020. COVID-19 diagnosis and management: a comprehensive review. J Intern Med. 288(2):192\u2013206.", "ArticleIdList": ["PMC7267177", "32348588"]}, {"Citation": "Rahman F, Tabrez S, Ali R, Alqahtani AS, Ahmed MZ, Rub A.. 2021. Molecular docking analysis of rutin reveals possible inhibition of SARS-CoV-2 vital proteins. J Tradit Complement Med. 11(2):173\u2013179.", "ArticleIdList": ["PMC7825826", "33520682"]}, {"Citation": "Rahman N, Basharat Z, Yousuf M, Castaldo G, Rastrelli L, Khan H.. 2020. Virtual screening of natural products against type II transmembrane serine protease (TMPRSS2), the priming agent of coronavirus 2 (SARS-CoV-2). Molecules. 25(10):2271.", "ArticleIdList": ["PMC7287752", "32408547"]}, {"Citation": "Rehman MT, AlAjmi MF, Hussain A.. 2020. Natural compounds as inhibitors of SARS-CoV-2 main protease (3CLpro): a molecular docking and simulation approach to combat COVID-19. Curr Pharm Des. 27:3577\u20133589.", "ArticleIdList": ["33200697"]}, {"Citation": "Rogero MM, Le\u00e3o MC, Santana TM, Pimentel M, Carlini GCG, da Silveira TFF, Gon\u00e7alves RC, Castro IA.. 2020. Potential benefits and risks of omega-3 fatty acids supplementation to patients with COVID-19. Free Radic Biol Med. 156:190\u2013199.", "ArticleIdList": ["PMC7350587", "32653511"]}, {"Citation": "Ryu YB, Jeong HJ, Kim JH, Kim YM, Park J-Y, Kim D, Naguyen TTH, Park S-J, Chang JS, Park KH, et al. 2010. Biflavonoids from Torreya nucifera displaying SARSCoV 3CLpro inhibition. Bioorg Med Chem. 18(22):7940\u20137947.", "ArticleIdList": ["PMC7126309", "20934345"]}, {"Citation": "Saakre M, Mathew D, Ravisankar V.. 2021. Perspectives on plant flavonoid quercetin-based drugs for novel SARS-CoV-2. Beni-Seuf Univ J Appl. 10(1):1\u201313.", "ArticleIdList": ["PMC7989718", "33782651"]}, {"Citation": "Satarker S, Nampoothiri M.. 2020. Structural proteins in severe acute respiratory syndrome coronavirus-2. Arch Med Res. 51(6):482\u2013491.", "ArticleIdList": ["PMC7247499", "32493627"]}, {"Citation": "Saxena SK, Kumar S, Baxi P, Srivastava N, Puri B, Ratho RK.. 2020. Chasing COVID-19 through SARS-CoV-2 spike glycoprotein. VirusDis. 31(4):399\u2013407.", "ArticleIdList": ["PMC7718591", "33313362"]}, {"Citation": "Senapati S, Banerjee P, Bhagavatula S, Kushwaha PP, Kumar S.. 2021. Contributions of human ACE2 and TMPRSS2 in determining host\u2013pathogen interaction of COVID-19. J Genet. 100(1):12.", "ArticleIdList": ["PMC7904510", "33707363"]}, {"Citation": "Sepay N, Sekar A, Halder UC, Alarifi A, Afzal M.. 2021. Anti-COVID-19 terpenoid from marine sources: a docking, admet and molecular dynamics study. J Mol Struct. 1228:1\u20138.", "ArticleIdList": ["PMC7547581", "33071352"]}, {"Citation": "Sharma A, Tiwari S, Deb MK, Marty JL.. 2020. Severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2): a global pandemic and treatment strategies. Int J Antimicrob. 56(2):1\u201313.", "ArticleIdList": ["PMC7286265", "32534188"]}, {"Citation": "Siniavin AE, Nikiforova MA, Grinkina SD, Gushchin VA, Starkov VG, Osipov AV, Tsetlin VI, Utkin YN.. 2021. Snake venom phospholipases A2 possess a strong virucidal activity against SARS-CoV-2 in\u00a0vitro and block the cell fusion mediated by spike glycoprotein interaction with the ACE2 receptor. bioRxiv. 12(1):1\u201327."}, {"Citation": "Song S, Peng H, Wang Q, Liu Z, Dong X, Wen C, Ai C, Zhang Y, Wang Z, Zhu B.. 2020. Inhibitory activities of marine sulfated polysaccharides against SARS-CoV-2. Food Funct. 11(9):7415\u20137420.", "ArticleIdList": ["32966484"]}, {"Citation": "Surti M, Patel M, Adnan M, Moin A, Ashraf SA, Siddiqui AJ, Snoussi M, Deshpande S, Reddy MN.. 2020. Ilimaquinone (marine sponge metabolite) as a novel inhibitor of SARS-CoV-2\u2009key target proteins in comparison with suggested COVID-19 drugs: designing, docking and molecular dynamics simulation study. RSC Adv. 10(62):37707\u201337720."}, {"Citation": "Taglialatela-Scafati O. 2021. New hopes for drugs against COVID-19 come from the sea. Mar Drugs. 19(2):104.", "ArticleIdList": ["PMC7916939", "33670191"]}, {"Citation": "Thomas S. 2020. The structure of the membrane protein of SARS-CoV-2 resembles the sugar transporter semiSWEET. Pathog Immun. 5(1):342\u2013363.", "ArticleIdList": ["PMC7608487", "33154981"]}, {"Citation": "Usefulness of topic ivermectin and carrageenan to prevent contagion of Covid 19 (IVERCAR) . 2020. Bethesda (MD): ClinicalTrials. Gov 2021; [accessed 2021 Jun 20]. https://clinicaltrials.gov/."}, {"Citation": "Verma AK. 2020. Cordycepin: a bioactive metabolite of Cordyceps militaris and polyadenylation inhibitor with therapeutic potential against COVID-19. J Biomol Structure Dynam. 38(4):1\u20138.", "ArticleIdList": ["PMC7754931", "33225826"]}, {"Citation": "Vijayaraj R, Altaff K, Rosita AS, Ramadevi S, Revathy J.. 2020. Bioactive compounds from marine resources against novel corona virus (2019-nCoV): In silico study for corona viral drug. Nat Prod Res. 34(4):1\u20135.", "ArticleIdList": ["32643410"]}, {"Citation": "Vitamin D, omega-3, and combination vitamins B, C and zinc supplementation for the treatment and prevention of COVID-19 . 2021. Bethesda (MD): ClinicalTrials. Gov; [accessed 2021 May 12]. https://clinicaltrials.gov/."}, {"Citation": "Vivar-Sierra A, Araiza-Mac\u00edas MJ, Hern\u00e1ndez-Contreras JP, Vergara-Casta\u00f1eda A, Ram\u00edrez-V\u00e9lez G, Pinto-Almaz\u00e1n R, Salazar JR, Loza-Mej\u00eda MA.. 2021. In silico study of polyunsaturated fatty acids as potential SARS-CoV-2 spike protein closed conformation stabilizers: epidemiological and computational approaches. Molecules. 26(3):711.", "ArticleIdList": ["PMC7866518", "33573088"]}, {"Citation": "Wabo Pon\u00e9 J, Fossi Tankoua O, Yondo J, Komtangi MC, Mbida M, Bilong Bilong CF.. 2011. The in\u00a0vitro effects of aqueous and ethanolic extracts of the leaves of Ageratum conyzoides (Asteraceae) on three life cycle stages of the parasitic nematode Heligmosomoides bakeri (Nematoda: Heligmosomatidae). Vet Med Int. 2011:140293\u2013140295.", "ArticleIdList": ["PMC3134952", "21772960"]}, {"Citation": "Watson DA, Hester J, et al. . 2008. Chapter 27 \u2013 infectious disease. In: Ballweg R, Sullivan EM, Brown D., editors. Physician assistant (4th ed.). Philadelphia: W.B. Saunders; p. 515\u2013525."}, {"Citation": "White KM, Rosales R, Yildiz S, Kehrer T, Miorin L, Moreno E, Jangra S, Uccellini MB, Rathnasinghe R, Coughlan L, et al. . 2021. Plitidepsin has potent preclinical efficacy against SARS-CoV-2 by targeting the host protein eEF1A. Science. 371(6532):926\u2013931.", "ArticleIdList": ["PMC7963220", "33495306"]}, {"Citation": "WHO coronavirus (COVID-19) dashboard . 2021. Geneva: World Health Organization; [accessed 2021 Feb 12]. https://www.who.int/."}, {"Citation": "Yadav R, Chaudhary JK, Jain N, Chaudhary PK, Khanra S, Dhamija P, Sharma A, Kumar A, Handu S.. 2021. Role of structural and non-structural proteins and therapeutic targets of SARS-CoV-2 for COVID-19. Cells. 10(4):821.", "ArticleIdList": ["PMC8067447", "33917481"]}, {"Citation": "Yu J-W, Wang L, Bao L-D.. 2020. Exploring the active compounds of traditional Mongolian medicine in intervention of novel coronavirus (COVID-19) based on molecular docking method. J Funct Foods. 71(104016):104016\u2013104011.", "ArticleIdList": ["PMC7225714", "32421102"]}, {"Citation": "Zhan Y, Ta W, Tang W, Hua R, Wang J, Wang C, Lu W.. 2021. Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro. Drug Dev Res. 82(8):1124\u20131130.", "ArticleIdList": ["PMC8251057", "33847382"]}], "ReferenceList": []}], "History": [{"Year": "2022", "Month": "3", "Day": "2", "Hour": "12", "Minute": "18"}, {"Year": "2022", "Month": "3", "Day": "3", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "15", "Hour": "6", "Minute": "0"}, {"Year": "2022", "Month": "3", "Day": "2"}], "PublicationStatus": "ppublish", "ArticleIdList": ["35234563", "PMC8896193", "10.1080/13880209.2022.2039215"]}}], "PubmedBookArticle": []}